Return
Tackling cardiovascular diseases with a new generation of polypills
CHANNEL
Topic: Epidemiology
Session type: Industry Q&A session
Date: Time:* -
See more details
Watch Replay
Chairperson
Charalambos Vlachopoulos (Athens, Greece)
Subtitle
Sponsored by SERVIER
Learning objectives
Dyslipidemia and hypertension are the most important risks factors of cardiovascular diseases The more frequent use of a new generation of polypills is the best way to optimize adherence to treatment and thus prognosis in cardiovascular patients
Presentations
Introduction.
Speaker: Charalambos Vlachopoulos (Athens, Greece)
Time:
View On Demand
Benefits of controlling both blood pressure and LDL-cholesterol in terms of cardiovascular protection.
Speaker: Bryan Williams (London, United Kingdom of Great Britain & Northern Ireland)
Time:
View On Demand
From pathophysiology to clinical benefits: what new combinations of a statin and antihypertensive drugs can provide.
Speaker: Claudio Borghi (Bologna, Italy)
Time:
View On Demand
Questions and Answers.
Time:
View On Demand
Conclusion.
Speaker: Charalambos Vlachopoulos (Athens, Greece)
Time:
View On Demand